iFIND TBR — Tuberculosis and Rifampicin Resistance Detection Kit
Manufacturer: Rocgene
Manufacturer-provided informationAll technical parameters below are manufacturer-provided information. Local regulatory status is not verified.
Product parameters
Product type
IVD Reagent Kit
Intended use
The iFIND TBR (MTB/RIF) Kit is intended for the detection of Mycobacterium tuberculosis complex DNA and genetic mutations associated with resistance to rifampicin.
Detection targets: IS6110, IS1081 (manufacturer ordering information in one document lists IS1087 — this discrepancy is documented and pending verification), rpoB (81 bp rifampicin resistance-determining region, complete RRDR mutation coverage).
Detection time: ≤120 minutes (per IFU). Manufacturer brochure states 85 minutes under optimal conditions — this time discrepancy is documented and pending clarification.
Amplification: Nested PCR with molecular beacon multiplex probe melting curve.
Local regulatory status not verifiedLocal regulatory, import and service status per market. All fields default to "not checked" until independently verified.
Market
Registration
Import
Evaluation
Commercial availability
Service
Local-language docs
Global (EN)Active
Not checked
Not checked
None
Not checked
Not checked
Missing
Russia (RU)
Not checked
Not checked
None
Not checked
Not checked
Missing
India (IN)
Not checked
Not checked
None
Not checked
Not checked
Missing
Claims & evidence
Manufacturer-provided informationGlobal
The iFIND TBR Kit detects Mycobacterium tuberculosis complex and identifies resistance to rifampicin and isoniazid.
Manufacturer-provided informationGlobal
The iFIND platform has CE-IVD marking.
Manufacturer-provided informationGlobal
The iFIND TBR Kit has a limit of detection of 10 CFU per reaction for Mycobacterium tuberculosis.